Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX4RQS
|
||||
| Drug Name |
propyl N-{19-methyl-14-oxo-3-propyl-3,13,19,20-tetraazahexacyclo[14.7.0.0^{2,10}.0^{4,9}.0^{11,15}.0^{17,21}]tricosa-1(16),2(10),4,6,8,11(15),17,20-octaen-7-yl}carbamate
|
||||
| Synonyms |
CHEMBL373575
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C27H29N5O3
|
||||
| Canonical SMILES |
CCCOC(=O)Nc1ccc2c(c1)c3c4CNC(=O)c4c5c(CCc6nn(C)cc56)c3n2CCC
|
||||
| InChI |
InChI=1S/C27H29N5O3/c1-4-10-32-21-9-6-15(29-27(34)35-11-5-2)12-17(21)23-18-13-28-26(33)24(18)22-16(25(23)32)7-8-20-19(22)14-31(3)30-20/h6,9,12,14H,4-5,7-8,10-11,13H2,1-3H3,(H,28,33)(H,29,34)
|
||||
| InChIKey |
QHABZPKWSAGTLE-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Vascular endothelial growth factor receptor 2 | Target Info | [1587926] | ||
| Angiopoietin 1 receptor | Target Info | [1587926] | |||
| NetPath Pathway | IL2 Signaling PathwayNetPath_8:Wnt Signaling Pathway | ||||
| PANTHER Pathway | Angiogenesis | ||||
| VEGF signaling pathwayP00005:Angiogenesis | |||||
| Pathway Interaction Database | HIF-2-alpha transcription factor network | ||||
| Beta3 integrin cell surface interactions | |||||
| Signaling events mediated by TCPTP | |||||
| SHP2 signaling | |||||
| S1P1 pathway | |||||
| VEGF and VEGFR signaling network | |||||
| Integrins in angiogenesis | |||||
| Signaling events mediated by VEGFR1 and VEGFR2 | |||||
| Notch-mediated HES/HEY networkangiopoietinreceptor_pathway:Angiopoietin receptor Tie2-mediated signaling | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.